CureVac NV (CVAC)
3.89
+0.12
(+3.18%)
USD |
NASDAQ |
May 31, 16:00
3.88
-0.01
(-0.26%)
After-Hours: 20:00
CureVac Enterprise Value: 544.31M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 544.31M |
| May 30, 2024 | 517.39M |
| May 29, 2024 | 521.88M |
| May 28, 2024 | 494.96M |
| May 24, 2024 | 499.45M |
| May 23, 2024 | 562.25M |
| May 22, 2024 | 548.79M |
| May 21, 2024 | 409.72M |
| May 20, 2024 | 434.40M |
| May 17, 2024 | 454.59M |
| May 16, 2024 | 452.34M |
| May 15, 2024 | 387.29M |
| May 14, 2024 | 367.11M |
| May 13, 2024 | 337.95M |
| May 10, 2024 | 324.49M |
| May 09, 2024 | 340.19M |
| May 08, 2024 | 317.76M |
| May 07, 2024 | 342.43M |
| May 06, 2024 | 332.34M |
| May 03, 2024 | 373.84M |
| May 02, 2024 | 293.09M |
| May 01, 2024 | 266.17M |
| April 30, 2024 | 237.01M |
| April 29, 2024 | 237.01M |
| April 26, 2024 | 194.39M |
| Date | Value |
|---|---|
| April 25, 2024 | 189.91M |
| April 24, 2024 | 234.77M |
| April 23, 2024 | 254.95M |
| April 22, 2024 | 239.25M |
| April 19, 2024 | 219.06M |
| April 18, 2024 | 219.06M |
| April 17, 2024 | 248.22M |
| April 16, 2024 | 269.53M |
| April 15, 2024 | 266.17M |
| April 12, 2024 | 324.49M |
| April 11, 2024 | 335.70M |
| April 10, 2024 | 333.46M |
| April 09, 2024 | 337.95M |
| April 08, 2024 | 360.38M |
| April 05, 2024 | 358.13M |
| April 04, 2024 | 335.70M |
| April 03, 2024 | 324.49M |
| April 02, 2024 | 317.76M |
| April 01, 2024 | 340.19M |
| March 31, 2024 | 351.41M |
| March 28, 2024 | 231.83M |
| March 27, 2024 | 236.32M |
| March 26, 2024 | 211.65M |
| March 25, 2024 | 258.75M |
| March 22, 2024 | 236.32M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
189.91M
Minimum
Apr 25 2024
23.53B
Maximum
Dec 09 2020
5.251B
Average
1.930B
Median
Jun 17 2022
Enterprise Value Benchmarks
| BioNTech SE | 7.581B |
| Affimed NV | -1.670M |
| InflaRx NV | -5.829M |
| MorphoSys AG | 2.712B |
| Immatics NV | 526.64M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -76.63M |
| Revenue (Quarterly) | 13.44M |
| Total Expenses (Quarterly) | 94.08M |
| EPS Diluted (Quarterly) | -0.3367 |
| Gross Profit Margin (Quarterly) | -236.9% |
| Profit Margin (Quarterly) | -570.2% |
| Earnings Yield | -34.02% |
| Normalized Earnings Yield | -34.27 |